Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion

Viral Immunology , Vol. 0, No. 0.


from #ENT via xlomafota13 on Inoreader http://ift.tt/1VMnR4G
via IFTTT